Givaudan Faces Valuation Hurdles Despite Solid Organic Growth

Givaudan SA continues to maintain a 'Hold' rating as analysts signal that the stock's current valuation remains high. Despite a significant drop from its peak, the market price of approximately CHF 2,700 significantly exceeds the estimated DCF fair value of CHF 2,170. The company reported solid organic growth of 5.1% in like-for-like sales for 2025, demonstrating underlying business resilience. However, persistent headwinds from currency fluctuations and margin compression continue to weigh on the overall financial outlook. Analysts suggest that the current price requires overly optimistic growth assumptions that may not be sustainable in the near term. Consequently, the stock is not yet considered attractive enough for a 'Buy' recommendation at these levels.